Skip to main content
. Author manuscript; available in PMC: 2009 Apr 1.
Published in final edited form as: Eur Urol. 2008 Jan 15;53(4):709–719. doi: 10.1016/j.eururo.2008.01.015

Table 2. TUR plus one immediate instillation followed by short-term versus long-term instillations during 12 mo.

Study Year Drug % single tumors Recurrence/total no. of patients p

Short-term instillations Long-term instillations (12 mo)
Bouffioux [13] 1995 MMC 30 mg/50 ml 62% 70/160 (43.8%) 67/150 (44.7%) 0.87
ADM 50 mg/50 ml
Okamura [14] 1998 Epirubicin 40 mg/40 ml 67% NA/69 (22.8%) NA/69 (24.9%) 0.62*
2 yr 2 yr
Koga [15] 2004 Epirubicin 30 mg/30 ml 61% 23/73 (31.5%) 10/77 (13.0%) 0.005*
0.006

Treatment schedules: reference 13: 9 instillations during 6 mo vs. 15 instillations during 12 mo; reference 14: 6 instillations during 1 mo vs. 17 instillations during 12 mo; reference 15: 9 instillations during 3 mo vs. 19 instillations during 12 mo. TUR = transurethral resection; MMC = mitomycin C; ADM = Adriamycin; NA = not available.

*

Log-rank test.